Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients

Hiromitsu Araki, Xiaoliang Pang, Nobukazu Komatsu, Mikiko Soejima, Nawoe Miyata, Mari Takaki, Shigeru Muta, Tetsuro Sasada, Masanori Noguchi, Yoshiro Koda,

Cancer Immunology Immunotherapy · 2015 · 11 citations · 27 references

DOIFull text

Open access

Concepts

References

27